FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...

Without presbyopia-correcting IOLs, most patients undergoing cataract surgery experience poor near vision requiring vision correction such as reading glasses or contact lenses. The AcrySof IQ ReSTOR ...

April 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved a rechargeable neurostimulation system to aid in the management of chronic intractable pain of the trunk and/or limbs; a dural ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

SAN FRANCISCO (MarketWatch) -- Alcon Inc. said Wednesday after the closing bell that the Food and Drug Administration has granted approval for its intraocular lens, AcrySof ReSTOR, to be used by ...

Oct. 27, 2004 (New Orleans) — New data from a European trial of the AcrySof ReSTOR MA60D3 intraocular lens (IOL) shows that overall 74% of bilateral cataract patients did not use glasses for near or ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

For years, patients who underwent cataract surgery had to wear glasses or contact lenses afterwards to see clearly. The newly developed ReSTOR® lens has overcome this problem, allowing patients to see ...

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses This ...